DV 601

N/A

Report date: 2025/12/23 20:00:10

Base Information

Drug NameDV 601
Drug Alias NameHBV therapy - DynavaxTheravax programme - DynavaxTherapeutic hepatitis B vaccine (DV-601) - DynavaxDV-601
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDynavax Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDynavax Technologies Corp
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A